PLIANT THERAPEUTICS, INC. Balance Sheet
PLRX|6 years of annual SEC 10-K data (FY2020-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 6 fiscal years. All figures from audited SEC 10-K filings.
PLIANT THERAPEUTICS, INC. had $225M in total assets and $304M in shareholders' equity as of FY2025. Total debt was $0 against $45M in cash, resulting in a $45M net cash position.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -4.20 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $45.4M | $71.2M | $63.2M | $33.7M | $51.7M | $50.9M |
| Accounts Receivable | - | - | - | $2.0M | $2.0M | $9.3M |
| Current Assets | $196.4M | $362.3M | $505.5M | $340.3M | $209.4M | $290.8M |
| PP&E (Net) | $2.9M | $5.5M | $3.6M | $4.5M | $4.6M | $4.3M |
| Total Assets | $225.2M | $396.9M | $512.2M | $350.6M | $221.2M | $295.5M |
| Current Liabilities | $16.4M | $33.2M | $28.5M | $23.9M | $16.8M | $11.6M |
| Total Debt | $0 | $30.2M | $10.1M | $9.9M | - | - |
| Shareholders' Equity | $304.1M | $473.6M | $199.1M | $283.1M | $283.1M | -$71.5M |